BeamMed Inc. at the RISE Qualipalooza Summit 2026, Showcasing Portable Screening Solutions That Support Medicare & Medicaid Quality Performance

June 24 07:06 2026
BeamMed Inc. at the RISE Qualipalooza Summit 2026, Showcasing Portable Screening Solutions That Support Medicare & Medicaid Quality Performance
RISE Qualipalooza Summit 2026
BeamMed Inc. will exhibit at the RISE Qualipalooza Summit 2026, June 28-30 at Omni PGA Frisco in Frisco, Texas, showcasing portable bone density screening and AI-powered preventive care technologies that help Medicare and Medicaid organizations improve quality performance, close care gaps, and support long-term outcomes.

As Medicare and Medicaid health plans face escalating pressure to improve quality scores across all four domains of quality improvement, the question driving strategy for quality directors and care management teams nationwide is clear: How do plans close persistent care gaps, achieve and maintain high performance scores, and ultimately deliver better outcomes for their members — year after year?

BeamMed Inc., a global leader in portable bone density screening technology, will be exhibiting at the RISE Qualipalooza Summit 2026, taking place June 28–30, 2026 at the Omni PGA Frisco, Frisco, TX. BeamMed will demonstrate how its innovative, point-of-care screening solutions help Medicare Advantage and Medicaid plans measurably improve quality measure compliance — and by extension, elevate their overall quality scores and bonus performance.

Why the RISE Qualipalooza Summit 2026 Matters

The RISE Qualipalooza Summit 2026 is a specialized conference purpose-built for Medicare and Medicaid quality professionals. Distinguished as the only conference covering all four areas of quality improvement in-depth, this event delivers the focused, expert-led insights that quality teams need to achieve high scores and sustain them over the long term.

Key themes and opportunities at this year’s summit include:

  • Comprehensive quality improvement coverage: All four domains addressed in depth — a unique differentiator from any other quality conference
  • Expert-led learning: Decades of experience from quality measure specialists who understand what it takes to move the needle on performance scores
  • Member care improvement: Strategies to improve care outcomes for Medicare and Medicaid members, not just documentation
  • Achieving and sustaining high scores: Practical frameworks to reach top-tier quality scores and maintain them over extended periods
  • Networking with quality professionals: Meaningful peer connections with professionals who share the same goals and challenges

For BeamMed, the Qualipalooza Summit is a natural platform to connect clinical-grade screening technology with the quality measures that directly influence a plan’s financial performance and member health outcomes.

The Osteoporosis Screening Gap: A Critical Quality Improvement Opportunity

Osteoporosis remains one of the most undertreated and underdiagnosed conditions among Medicare-age women. According to the National Osteoporosis Foundation, approximately 10 million Americans have osteoporosis, yet screenings and follow-up care remain persistently low — a gap that directly impacts two core quality measures:

  • HEDIS OMW (Osteoporosis Management in Women who had a Fracture): Measures whether women aged 67–85 who suffered a fracture received a bone mineral density test or prescription treatment within six months.
  • HEDIS OSW (Osteoporosis Screening in Older Women): Evaluates whether women aged 65–85 without prior fractures received a bone density test within two years.

Both measures directly affect a plan’s quality score and Star Rating, making them core priorities for any Medicare Advantage plan aiming to maintain or improve its competitive position. Closing these gaps requires accessible, accurate, and affordable bone density testing — exactly where BeamMed’s technology delivers.

BeamMed’s Solution: Portable Bone Density Screening at the Point of Care

BeamMed’s flagship device, the Sunlight MiniOmni™ portable bone density scanner, is revolutionizing how primary care physicians, OB/GYN practices, and health system networks approach osteoporosis screening. Using proven quantitative ultrasound (QUS) technology — with no radiation, no dedicated room requirements, and no referral delays — the MiniOmni™ enables in-office bone density testing in just minutes.

Practical advantages for Medicare and Medicaid plans and their provider networks include:

  • Rapid gap closure: Providers can screen eligible women during routine visits, dramatically increasing quality measure compliance rates
  • No radiation exposure: Safe for repeated use, making follow-up and monitoring straightforward
  • Portable and affordable: No costly infrastructure investment or scheduling delays typically associated with DXA imaging
  • Multi-site measurement capability: Assesses bone density at multiple anatomical sites for greater clinical accuracy
  • Seamless EHR integration: Results flow directly into clinical documentation, supporting care coordination and quality reporting

Plans working with BeamMed have reported meaningful improvements in their HEDIS osteoporosis measure rates, translating into higher quality scores and stronger quality bonus payments.

What to Expect at BeamMed’s Exhibit Booth in Frisco, TX

Attendees of the RISE Qualipalooza Summit 2026 at the Omni PGA Frisco will have the opportunity to engage directly with BeamMed’s clinical and commercial team throughout the conference. At the exhibit booth, visitors can expect:

  • Live demonstrations of the MiniOmni™ bone density scanner
  • Strategy consultations on improving HEDIS OMW and OSW measure performance and maintaining high scores
  • A showcase of BeamMed’s AI fundus camera, expanding screening capabilities for diabetic retinopathy — another high-impact area of Medicare quality improvement
  • Discussion of real-world ROI data from health plans and provider groups that have integrated BeamMed’s technology
  • Resources and frameworks for implementing point-of-care screening at scale across provider networks

Register now and plan your visit to BeamMed’s booth at the RISE Qualipalooza Summit 2026 to discover how portable screening is reshaping quality improvement strategy for Medicare and Medicaid plans nationwide.

About BeamMed Inc.

BeamMed’s product line offers innovative, non-invasive diagnostic solutions focused on bone and ocular health. Widely used across clinics, hospitals, and mobile healthcare programs throughout the U.S., these tools are designed to make early detection more accessible, efficient, and accurate. With a strong emphasis on usability and clinical performance, BeamMed’s offerings continue to support the advancement of preventive care nationwide.

To learn more, visit: www.beammed.com

Media Contact
Company Name: BeamMed Inc.
Contact Person: Gilad Zamir
Email: Send Email
Phone: 800-769-6808
Address:950 S. Pine Island Road
City: Plantation
State: Florida
Country: United States
Website: www.beammed.com